O'Brien Greene & Co. Inc Bristol Myers Squibb CO Transaction History
O'Brien Greene & Co. Inc
- $303 Million
- Q2 2024
A detailed history of O'Brien Greene & Co. Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 6,304 shares of BMY stock, worth $335,309. This represents 0.09% of its overall portfolio holdings.
Number of Shares
6,304
Previous 6,108
3.21%
Holding current value
$335,309
Previous $331,000
21.15%
% of portfolio
0.09%
Previous 0.11%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,428Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.92 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.44 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.86 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.97 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.14 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $113B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...